L-Carnitine and Alpha-Lipoic Acid (ALA)
In Canada, GLP-1 medications are already a significant driver of drug plan spending an Alberta Blue Cross report that reviewed new drug and supplemental submissions made to Health Canada in 2025 named such treatments as a major cost of employer-sponsored drug plans, particularly as the drugs are approved for treatment of more conditions
Saxenda is FDA-approved for chronic weight management and is delivered by injection
Storage: Keep in a cool, dry place away from direct sunlight
Additionally, peptides should be kept in tightly sealed containers for example vials to protect them from moisture and air exposure, which can compromise their quality
It is a well-characterized, mechanistically specific peptide with a 30-year research history, a strong clinical safety record from formal trials, and modest but real efficacy data from 12-week studies